How Big Food Is Navigating the GLP-1 Era
The food industry is undergoing a seismic shift as GLP-1 weight loss drugs like Wegovy alter consumer appetites, cravings, and taste perception, prompting major food companies to reformulate products to appeal to a new class of health-conscious, appetite-suppressed users. With projections
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Amira McKee
narrative on The Journal.
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Products & Tools
Research & Papers
Topics
Listen to This Episode
More from The Journal.
Novo Nordisk's CEO Has a Comeback Plan
Weight-Loss Drugs Are Gobbling Up Small Town Budgets
The MAHA Shake-Up at Steak ‘n Shake
McDonald’s and Coke's Marriage Might Need a Refresher
What's Going On With Lettuce?
The Bankruptcy That's Ruining Dinner
Related episodes
From other shows on similar topics.
Reshaping the GLP-1 Economy: A Breaking Consumer Study
We Fixed It, You're Welcome
People are running their own experiments with GLP-1s — with stunning results
Apple News Today
Ozempic for All?
The Daily
Skinny and sad on GLP-1s
Today, Explained
What evolution reveals about eating, dieting and fat
Fresh Air
What we got wrong about GLP-1s
Search Engine
Get summaries like this every morning.
Free AI-powered recaps of The Journal. and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.